Realignment effective for pain in knee OA 5 Mar 2012 0 comments Treatment for knee osteoarthritis doesn’t always need to be in drug form, say rheumatologists who found that realigning knees in several ways had a significant effect on pain relief.
Golimumab effective after one year 5 Mar 2012 0 comments Golimumab has continued clinical efficacy and safety in treating active psoriatic arthritis through one year, new research shows.
New concerns over metal hip implants 5 Mar 2012 0 comments Fresh evidence has emerged about the toxicity of all-metal hip protheses implanted in thousands of Australians, just months after a Senate committee described the situation as a ticking "time bomb".
Methotrexate ineffective against synovitis in psoriatic arthritis 27 Feb 2012 0 comments Methotrexate has no beneficial effect on synovitis in patients with psoriatic arthritis despite being widely recommended as a standard treatment.
Zoledronic acid good for pain in OA 27 Feb 2012 0 comments A single 5mg infusion of zoledronic acid (ZA) reduces pain and significantly shrinks bone marrow lesions in patients with knee osteoarthritis, an Australian trial has shown.
Self management of knee-OA a success 27 Feb 2012 0 comments Turning the tide on earlier studies, a new randomised trial suggests professionally-guided self-management for knee osteoarthritis is effective.
RA biologics trials criticised 20 Feb 2012 0 comments Randomised trials of biologic therapies for rheumatoid arthritis have failed to provide enough head-to-head comparisons and relied excessively on placebo controls that have placed patients at risk of…
Diabetes screening different for patients on prednisolone 20 Feb 2012 0 comments Rheumatology patients taking prednisolone long-term should be screened for diabetes using an oral glucose tolerance test, Australian experts say.
Shock jock costs Sanofi for drug mention 20 Feb 2012 0 comments A shock jock radio interview which promoted the osteoporosis drug Actonel EC has landed its maker with a $40,000 fine.
Ban on painkillers stalled 20 Feb 2012 0 comments The ban on two painkillers containing dextropropoxyphene has been stalled pending an appeal from the drugs' manufacturer.
